English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

We read the recent publication entitled “ Study of microalbuminuria as a nephropathic marker in type 2 diabetes mellitus and its correlation with the glycated hemoglobin” published by Patil A R, et al.1with great interest in which the authors have suggested that microalbuminuria as a nephropathic marker in type 2 diabetes mellitus. The possibility, delay or reverse the progression of diabetic nephropathy can be achieved only by perfect long term metabolic control.1Diabetic nephropathy is an important cause of chronic kidney disease that frequently leads to end stage kidney disease.2Diabetic nephropathy is first manifested as microalbuminuria, which progresses to overt albuminuria and then to renal failure.3 We found certain discrepancies which we want to bring to your notice. The selection of study subjects seems to be as biased. The authors have studied 50 subjects in each group (50 healthy controls and 50 type 2 Diabetes Mellitus patients). However, in a case-control study, it is very unusual to have the same number of total subjects in

international journal of clinical biochemistry and research

Letter to the editor regarding: “Patil A R et al., Study of microalbuminuria as a nephropathic marker in type 2 diabetes mellitus and its correlation with the glycated hemoglobin” Int J Clin Biochem Res 2019;6(4):479-484